Midlife Women's Health 2024: A Multidisciplinary Approach to Care

Description

Midlife Women’s Health 2024 provides a multi-disciplinary approach to the care of menopausal women. Advances in research, technology, and pharmacology increase options available for midlife women, but this rapidly changing knowledge-base presents a challenge for clinicians. Care for women at this stage of life is optimized by education on a range of medical concerns provided by experts from a wide variety of medical specialties. Given demographic changes in the U.S. population, midlife women are becoming an increasingly important group served by health care professionals, with needs that cross many areas of medical expertise.

In this educational activity, a multidisciplinary group of experts from Massachusetts General Hospital will present on the evaluation and management of gynecologic cancers, vascular disease, parathyroid disease and thyroid nodules, vulvovaginal disorders, lung cancer, cardiovascular health, attention deficit hyperactivity disorder, sexuality after cancer, and menopausal hormone therapy to assist clinicians in caring for their midlife patients. The entire program will be available to registrants for 30 days after the event, with CME credit provided only to those who log in on the day of the conference.

Target Audience

This educational activity is intended for physicians and advance practice nurses in primary care, gynecology, general surgery, internal medicine, endocrinology, psychiatry, gynecological oncology, cardiology, and preventive medicine who provide care to midlife women. Physicians and advance practice nurses in-training also are encouraged to attend.

Learning Objectives

Upon completion of this activity, participants will be able to:

1. Identify signs and symptoms of gynecologic cancers at midlife to optimize outcomes
2. Employ a greater understanding of vascular disease in aging women to reduce disease burden
3. Evaluate parathyroid disease and thyroid nodules in aging women
4. Assess midlife women for vulvovaginal disorders and guide the use of available treatment options
5. Recognize the link between stress, inflammation, and cardiovascular disease in women to improve health
6. Assess midlife women for attention deficit hyperactivity disorder and utilize effective therapies
7. Formulate a strategy to identify women at increased risk of lung cancer to optimize care
8. Integrate behavioral and pharmacologic strategies to improve sexual function for cancer survivors
9. Evaluate symptomatic midlife women for menopausal hormone therapy, incorporating an individualized assessment of risks and benefits

Friday, May 10, 2024

7:45 a.m. - Welcome & Introductory Remarks

Jan Shifren, MD

8:00 a.m. - Gynecologic Cancers: Update for 2024

Allison Gockley, MD & Varvara Mazina, MD

8:45 a.m. - Vascular Disease: Evaluation and Treatment in Older Women

Anahita Dua, MD, MS, MBA

9:30 a.m. - Parathyroid Disease and Thyroid Nodules: Diagnosis and Management

Rajshri Gartland, MD, MPH

10:15 a.m. - Break

10:30 a.m. - Vulvovaginal Disorders at Midlife: Beyond the Genitourinary Syndrome of Menopause

Alisa Pascale, DNP, WHNP-BC

11:15 a.m. - Stress, Inflammation & Cardiovascular Disease: Understanding the Link in Aging Women

Ahmed Tawakol, MD

12:00 p.m. - Lunch Break

1:00 p.m. - Beyond Adolescence—Impact of Attention Deficit Hyperactivity Disorder in Midlife Women

Allison Baker, MD

1:45 p.m. - Lung Cancer in Women: Optimizing Identification & Treatment

Lecia Sequist, MD , MPH

2:30 p.m. - Sexuality After Cancer

Don Dizon, MD

3:15 p.m. - Break

3:30 p.m. - Menopausal Hormone Therapy—Risks, Benefits & Alternatives

Deborah Kwolek, MD

4:15 p.m. - Everything You Wanted to Know About Menopause, But Were Afraid to Ask

Panel of Experts

5:00 p.m. - Program Concludes

Jan Shifren, MD - Course Director

Reproductive Endocrinologist
Director, Midlife Women’s Health Center, Department of Obstetrics and Gynecology, Massachusetts General Hospital
Vincent Trustees Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Allison Baker, MD

Psychiatrist, Perinatal and Reproductive Psychiatry Clinical Research Program, Massachusetts General Hospital
Instructor in Psychiatry, Harvard Medical School

Don Dizon, MD

Director, Pelvic Malignancies Program, Lifespan Cancer Institute
Head of Community Outreach & Engagement, Legorreta Cancer Center
Director of Medical Oncology, Rhode Island Hospital

Anahita Dua, MD, MS, MBA

Vascular Surgeon
Director, Vascular Lab
Co-director, Peripheral Artery Disease Center, Fireman Vascular Center, Massachusetts General Hospital
Associate Professor of Surgery, Harvard Medical School

Rajshri Gartland, MD, MPH

Endocrine Surgeon and Surgical Oncologist
Co-Director, Thyroid Radiofrequency Ablation Program
Assistant Chief Quality Officer, Massachusetts General Hospital
Assistant Professor of Surgery, Harvard Medical School

Allison Gockley, MD

Gynecologic Oncologist, Department of Obstetrics and Gynecology, Massachusetts General Hospital
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Linda Kelly, DNP, ANP-BC

Advanced Practice Provider
Nursing Director, Midlife Women's Health Center, Department of Obstetrics and Gynecology, Massachusetts General Hospital

Deborah Kwolek, MD

Lead, Women's Health and Sex- and Gender-Based Medicine Program
Director, Women's Health Resident Rotation, Department of Medicine, Massachusetts General Hospital
Chair, Women and Medicine Commission, Society of General Internal Medicine
Assistant Professor of Medicine, Harvard Medical School

Varvara Mazina, MD

Gynecologic Oncologist, Department of Obstetrics and Gynecology, Massachusetts General Hospital
Instructor in Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Alisa Pascale, DNP, WHNP-BC

Women's Health Nurse Practitioner, Department of Obstetrics and Gynecology
Clinical Instructor in the Women's Health Program, Institute of Health Professions, Massachusetts General Hospital

Isaac Schiff, MD

Chief Emeritus, Department of Obstetrics and Gynecology
Co-Director, Midlife Women's Health Center, Massachusetts General Hospital
Joe Vincent Meigs Distinguished Professor of Gynecology, Harvard Medical School

Lecia Sequist, MD, MPH

Medical Oncologist, Center for Thoracic Cancers
Program Director, Cancer Early Detection and Diagnostics Clinic, Mass General Cancer Center
Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital
Landry Family Professor of Medicine, Harvard Medical School

Ahmed Tawakol, MD

Cardiologist
Co-Director, Cardiac MR PET CT Program, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School

Course Tuition

Before March 29, 2024

After March 29, 2024

Cancellation Policy

Registrations cancelled on or before March 29, 2024, will be refunded, less a $35 administrative fee. Registrations cancelled after March 29, 2024, will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.

Please contact our Course Coordinator at MGHMidlifeCenter@mgh.harvard.edu prior to the event to assist you with any special needs.

Accreditation

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.